These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37024302)

  • 21. 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.
    Garkavij M; Nickel M; Sjögreen-Gleisner K; Ljungberg M; Ohlsson T; Wingårdh K; Strand SE; Tennvall J
    Cancer; 2010 Feb; 116(4 Suppl):1084-92. PubMed ID: 20127957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
    Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093
    [No Abstract]   [Full Text] [Related]  

  • 23. Generation of clinical
    Kayal G; Chauvin M; Vergara-Gil A; Clayton N; Ferrer L; Moalosi T; Knoll P; Struelens L; Bardiès M
    Phys Med; 2021 May; 85():24-31. PubMed ID: 33957577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with
    Roth D; Gustafsson J; Warfvinge CF; Sundlöv A; Åkesson A; Tennvall J; Gleisner KS
    J Nucl Med; 2022 Mar; 63(3):399-405. PubMed ID: 34272319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios.
    Kupitz D; Wetz C; Wissel H; Wedel F; Apostolova I; Wallbaum T; Ricke J; Amthauer H; Grosser OS
    PLoS One; 2017; 12(11):e0187570. PubMed ID: 29107992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Averaging of absorbed doses: How matter matters.
    Gustafsson J; Ljungberg M; Alm Carlsson G; Larsson E; Warfvinge CF; Asp P; Sjögreen Gleisner K
    Med Phys; 2023 Oct; 50(10):6600-6613. PubMed ID: 37272586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study.
    Chicheportiche A; Sason M; Godefroy J; Krausz Y; Zidan M; Oleinikov K; Meirovitz A; Gross DJ; Grozinsky-Glasberg S; Ben-Haim S
    EJNMMI Phys; 2021 Aug; 8(1):63. PubMed ID: 34436698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated
    Gupta A; Shin JH; Lee MS; Park JY; Kim K; Kim JH; Suh M; Park CR; Kim YJ; Song MG; Jeong JM; Lee DS; Lee YS; Lee JS
    Mol Pharm; 2019 Apr; 16(4):1498-1506. PubMed ID: 30821463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric implications of kidney anatomical volume changes in
    Khan J; Rydèn T; Van Essen M; Svensson J; Grudzinski J; Bernhardt P
    EJNMMI Phys; 2024 Aug; 11(1):71. PubMed ID: 39090481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DOSIS: An integrated computational tool for patient-specific dosimetry in nuclear medicine by Monte Carlo and dose point kernel approaches.
    Pérez P; Valente M
    Appl Radiat Isot; 2019 Aug; 150():135-140. PubMed ID: 31146217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Marrow Absorbed Doses and Correlations with Hematologic Response During
    Hagmarker L; Svensson J; Rydén T; van Essen M; Sundlöv A; Gleisner KS; Gjertsson P; Bernhardt P
    J Nucl Med; 2019 Oct; 60(10):1406-1413. PubMed ID: 30902877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [
    Kurth J; Krause BJ; Schwarzenböck SM; Bergner C; Hakenberg OW; Heuschkel M
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):123-135. PubMed ID: 31482426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate.
    Sandström M; Garske U; Granberg D; Sundin A; Lundqvist H
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):212-25. PubMed ID: 19727718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies.
    Hou X; Brosch J; Uribe C; Desy A; Böning G; Beauregard JM; Celler A; Rahmim A
    J Nucl Med; 2021 Jul; 62(7):1006-1011. PubMed ID: 33127625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized kidney dosimetry in
    Hou X; Zhao W; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175004. PubMed ID: 31456584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
    Delker A; Fendler WP; Kratochwil C; Brunegraf A; Gosewisch A; Gildehaus FJ; Tritschler S; Stief CG; Kopka K; Haberkorn U; Bartenstein P; Böning G
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):42-51. PubMed ID: 26318602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
    Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
    Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncertainty propagation for SPECT/CT-based renal dosimetry in (177)Lu peptide receptor radionuclide therapy.
    Gustafsson J; Brolin G; Cox M; Ljungberg M; Johansson L; Gleisner KS
    Phys Med Biol; 2015 Nov; 60(21):8329-46. PubMed ID: 26458139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Single Computed Tomography Attenuation Correction able to Surrogate Serial Computed Tomography Attenuation Correction in Single-Photon Emission Computed Therapy Imaging for Peptide Receptor Radionuclide Therapy Dosimetry Result?
    Said MAB; Razak HRA; Musarudin MB
    J Med Phys; 2022; 47(2):189-193. PubMed ID: 36212205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of image registration on 3D absorbed dose calculations in
    Grassi E; Fioroni F; Berenato S; Patterson N; Ferri V; Braglia L; Filice A; Versari A; Iori M; Spezi E
    Phys Med; 2018 Jan; 45():177-185. PubMed ID: 29472084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.